Search research articles
Contact Us
Filters
Showing results (1-10 of 107) with videos related to
Page
of 11
Sort By:
Clinical Liver Disease
|
April 18, 2019
Laboratory-based biomarkers to improve causality assessment in drug-induced liver injury
Daniel J Antoine
Expert Review of Clinical Pharmacology
|
January 24, 2014
Stratification of paracetamol overdose patients using new toxicity biomarkers: current candidates and future challenges
James W Dear, Daniel J Antoine
Expert Review of Clinical Pharmacology
|
February 17, 2016
How to treat paracetamol overdose and when to do it
Daniel J Antoine, James W Dear
Biomarkers in Medicine
|
January 19, 2017
Transformative biomarkers for drug-induced liver injury: are we there yet?
Daniel J Antoine, James W Dear
Lancet (London, England)
|
December 3, 2013
Treatment of paracetamol overdose: room for improvement?
Kevin Park, Daniel J Antoine, Munir Pirmohamed
Clinical and Translational Science
|
November 16, 2017
Repurposing Statins for Renal Protection: Is It a Class Effect?
Stephen J McWilliam, Daniel J Antoine, Munir Pirmohamed
Journal of Clinical and Translational Research
|
March 16, 2019
Novel circulating- and imaging-based biomarkers to enhance the mechanistic understanding of human drug-induced liver injury
Joanna I Clarke, Nathalie Brillanf, Daniel J Antoine
BMJ Clinical Evidence
|
October 20, 2015
Paracetamol (acetaminophen) poisoning
B Kevin Park, James W Dear, Daniel J Antoine
European Journal of Clinical Pharmacology
|
October 26, 2017
Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature
Thomas M Caparrotta, Daniel J Antoine, James W Dear
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
February 24, 2012
Validation of the isolation and quantification of kidney enriched miRNAs for use as biomarkers
Jack W Sharkey, Daniel J Antoine, B Kevin Park
Page
of 11
Search research articles
Search
Showing results (1-10 of 107) with videos related to
Sort By:
Page
of 11
Clinical Liver Disease
|
April 18, 2019
Laboratory-based biomarkers to improve causality assessment in drug-induced liver injury
Daniel J Antoine
Expert Review of Clinical Pharmacology
|
January 24, 2014
Stratification of paracetamol overdose patients using new toxicity biomarkers: current candidates and future challenges
James W Dear, Daniel J Antoine
Expert Review of Clinical Pharmacology
|
February 17, 2016
How to treat paracetamol overdose and when to do it
Daniel J Antoine, James W Dear
Biomarkers in Medicine
|
January 19, 2017
Transformative biomarkers for drug-induced liver injury: are we there yet?
Daniel J Antoine, James W Dear
Lancet (London, England)
|
December 3, 2013
Treatment of paracetamol overdose: room for improvement?
Kevin Park, Daniel J Antoine, Munir Pirmohamed
Clinical and Translational Science
|
November 16, 2017
Repurposing Statins for Renal Protection: Is It a Class Effect?
Stephen J McWilliam, Daniel J Antoine, Munir Pirmohamed
Journal of Clinical and Translational Research
|
March 16, 2019
Novel circulating- and imaging-based biomarkers to enhance the mechanistic understanding of human drug-induced liver injury
Joanna I Clarke, Nathalie Brillanf, Daniel J Antoine
BMJ Clinical Evidence
|
October 20, 2015
Paracetamol (acetaminophen) poisoning
B Kevin Park, James W Dear, Daniel J Antoine
European Journal of Clinical Pharmacology
|
October 26, 2017
Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature
Thomas M Caparrotta, Daniel J Antoine, James W Dear
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
February 24, 2012
Validation of the isolation and quantification of kidney enriched miRNAs for use as biomarkers
Jack W Sharkey, Daniel J Antoine, B Kevin Park
Page
of 11